✦ LIBER ✦

P-559 A phase II study of oxallplatln and docetaxel In patients with advanced non-small-cell lung cancer (NSCLC)

✍ Scribed by Raez, L.; Santos, E.; Rocha-Lima, C.; Roman, E.; Kumar, P.; Farfan, N.; Decesare, T.; Lopes, G.; Rosado, M.; Wu, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of modulated-capecitabi

✍ Bertino, Erin M.; Bekaii-Saab, Tanios; Fernandez, Soledad; Diasio, Robert B.; Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

P-230 A phase II study of weekly docetax

✍ Han, Ji-Youn; Lee, Dae Ho; Kim, Hae Young; Chun, Jong Ho; Yoon, Sung Min; Lee, H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

A Phase I study of Nedaplatin (CDGP) and

✍ Saito, J; Nakai, Y; Koinumaru, S; Matsuda, T; Saijo, Y; Nukiwa, T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

P-45 A phase II study of weekly docetaxe

✍ Minato, Koichi; Tsuchiya, Satoshi; Ishihara, Shin-ichi; Watanabe, Satoru; Takei, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Phase I/II trial of gemcitabine plus doc

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

Phase I study of cisplatin, docetaxel an

✍ Kiura, K; Ueoka, H; Eguchi, K; Segawa, Y; Takigawa, N; Kamei, H; Shibayama, T; H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB